Aspirin in primary prevention for patients with diabetes: Still a matter of debate

Patients with diabetes are at high cardiovascular (CV) risk due to an exaggerated platelet activation and aggregation. In the first 2000s low-dose aspirin was first recommended for primary prevention, but then re-discussed.This short narrative review, based on the material searched for and obtained via PubMed up to February 2018, aims at clarifying this controversial topic.The JPAD2 study has been designed to evaluate the occurrence of any CV...